Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Toxoplasma gondii infection may increase testosterone levels in males.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Women with different PCOS types have similar fertility treatment results.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Mutations in certain receptors can cause diseases and offer new treatment options.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that more research is needed to fully understand the causes of PCOS.

Oestrogens are key for bone growth during puberty in both boys and girls.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.